Literature DB >> 20887841

Does obesity impact lymph node retrieval in colon cancer surgery?

Jared H Linebarger1, Michelle A Mathiason, Kara J Kallies, Stephen B Shapiro.   

Abstract

BACKGROUND: Evaluation of lymph nodes is important for the optimal treatment of colon adenocarcinoma. Few studies have assessed whether lymph node harvest is compromised by obesity. We hypothesized that lymph node retrieval in colon cancer resection would be reduced in obese patients.
METHODS: Patients undergoing resection for colon adenocarcinoma diagnosed from 2000 to 2007 were reviewed retrospectively and stratified by body mass index (BMI). Lymph node harvest was evaluated.
RESULTS: A total of 401 patients were included. Their mean age was 72.8 years, and 44% were men. Their mean BMI was 28.2 kg/m(2). Mean lymph node recovery among BMI groups was as follows: BMI less than 18.5 was 20.6; BMI of 18.5 to 24.9 was 25.1; BMI of 25 to 29.9 was 23.1; BMI of 30 to 34.9 was 22.4; BMI of 35 to 39.9 was 19.0; and BMI of 40 or greater was 21.1 nodes (P = .321). Surgical time increased with increasing BMI (P = .005). Adequacy of node harvest differed by stage (P = .007), left-sided versus right-sided resections (P = .001), and pathology technician (P = .001).
CONCLUSIONS: Lymph node retrieval was not affected by BMI.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20887841     DOI: 10.1016/j.amjsurg.2009.12.012

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  16 in total

Review 1.  Evolution and future of laparoscopic colorectal surgery.

Authors:  Andreas M Kaiser
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

2.  Extended lymphadenectomy in colon cancer is debatable.

Authors:  Jamie Murphy; Tonia Young-Fadok
Journal:  World J Surg       Date:  2013-08       Impact factor: 3.352

3.  Does body mass index impact the number of LNs harvested and influence long-term survival rate in patients with stage III colon cancer?

Authors:  Yi-Hung Kuo; Kam-Fai Lee; Chih-Chien Chin; Wen-Shih Huang; Chung-Hung Yeh; Jeng-Yi Wang
Journal:  Int J Colorectal Dis       Date:  2012-05-25       Impact factor: 2.571

4.  Obesity was associated with a decreased postoperative recurrence of rectal cancer in a Japanese population.

Authors:  Ryo Seishima; Koji Okabayashi; Hirotoshi Hasegawa; Daisuke Sugiyama; Yoshiyuki Ishii; Masashi Tsuruta; Toru Takebayashi; Yuko Kitagawa
Journal:  Surg Today       Date:  2014-05-21       Impact factor: 2.549

5.  Lymph node retrieval after dissolution of surrounding adipose tissue for pathological examination of colorectal cancer.

Authors:  Hiromichi Maeda; Ken Okamoto; Koji Oba; Mai Shiga; Yuki Fujieda; Tsutomu Namikawa; Makoto Hiroi; Ichiro Murakami; Kazuhiro Hanazaki; Michiya Kobayashi
Journal:  Oncol Lett       Date:  2017-12-14       Impact factor: 2.967

Review 6.  Colorectal cancer and lymph nodes: the obsession with the number 12.

Authors:  Giovanni Li Destri; Isidoro Di Carlo; Roberto Scilletta; Beniamino Scilletta; Stefano Puleo
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

Review 7.  Non-surgical factors influencing lymph node yield in colon cancer.

Authors:  Patrick Wood; Colin Peirce; Jurgen Mulsow
Journal:  World J Gastrointest Oncol       Date:  2016-05-15

8.  Overweight patients achieve ideal body weight following curative gastrectomy resulting in better long-term prognosis.

Authors:  Fanming Kong; Hui Li; Yongli Fan; Xinwei Zhang; Shui Cao; JinPu Yu; Xiubao Ren; Xishan Hao
Journal:  Obes Surg       Date:  2013-05       Impact factor: 4.129

9.  Obesity and colorectal cancer.

Authors:  Irena Gribovskaja-Rupp; Lauren Kosinski; Kirk A Ludwig
Journal:  Clin Colon Rectal Surg       Date:  2011-12

10.  Colon cancer lymph node evaluation among military health system beneficiaries: an analysis by race/ethnicity.

Authors:  Abegail A Gill; Shelia H Zahm; Craig D Shriver; Alexander Stojadinovic; Katherine A McGlynn; Kangmin Zhu
Journal:  Ann Surg Oncol       Date:  2014-07-25       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.